Log in
ASX:PNV

PolyNovo Limited (PNV.AX) Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range
A$2.49
MA: A$2.49▼
A$2.49
52-Week Range N/A
Volume3.38 million shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Polynovo Limited develops medical devices in the United States, Australia, New Zealand, and internationally. The company offers NovoSorb Biodegradable Temporising Matrix, which is used in a fully debrided clean surgical wound to physiologically close the wound. It is also developing Syntrel hernia devices for hernia repair; breast devices in partnership with Establishment Labs; NovoSorb dermal beta cell implant in collaboration with BetaCell Technologies Pty Ltd; and NovoSorb drug elution depots. The company was formerly known as Calzada Limited and changed its name to Polynovo Limited in November 2014. Polynovo Limited was incorporated in 1998 and is based in Port Melbourne, Australia.

Beat the Market (BTM) Rank™

Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

0.54 out of 5 stars


Industry, Sector and Symbol

Stock Exchange ASX
Industry Biotechnology
Sub-IndustryN/A
SectorMedical
Current SymbolASX:PNV
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.polynovo.com.au
Phone61 3 8681 4050
EmployeesN/A

Debt

Debt-to-Equity Ratio42.13
Current Ratio2.04
Quick Ratio1.65

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$22.19 million
Price / Sales0.00
Cash FlowN/A
Price / Cash Flow207.50
Book ValueA$0.04 per share
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive PNV News and Ratings via Email

Sign-up to receive the latest news and ratings for PNV and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











PolyNovo Limited (PNV.AX) (ASX:PNV) Frequently Asked Questions

What stocks does MarketBeat like better than PolyNovo Limited (PNV.AX)?

Wall Street analysts have given PolyNovo Limited (PNV.AX) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but PolyNovo Limited (PNV.AX) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of PolyNovo Limited (PNV.AX)'s key competitors?

Some companies that are related to PolyNovo Limited (PNV.AX) include (CHV) (CHV), (DDXS) (DDXS), (PREV) (PREV), (TNGN) (TNGN), 138267 (COM.TO) (COM), 17031 (MYM), Abattis Bioceuticals (ATTBF), Abzena plc (ABZA.L) (ABZA), Acrux Limited (ACR.AX) (ACR), Actinogen Medical Limited (ACW.AX) (ACW), AdAlta Limited (1AD.AX) (1AD), ADiTx Therapeutics (ADTX), Admedus (AHZ), Alaric (HALB) and Almirall (LBTSF).
View all competitors.

What other stocks do shareholders of PolyNovo Limited (PNV.AX) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other PolyNovo Limited (PNV.AX) investors own include Immutep (IMMP), Rural Funds Group (RFF.AX) (RFF), Vanguard FTSE Pacific Index Fund ETF Shares (VPL), UQM Technologies (UQM), Tesla (TSLA), Starpharma Holdings Limited (SPL.AX) (SPL), Moelis Australia Limited (MOE.AX) (MOE), iSignthis (ISX), Align Technology (ALGN) and Acasti Pharma (ACST).

Who are PolyNovo Limited (PNV.AX)'s key executives?

PolyNovo Limited (PNV.AX)'s management team includes the following people:
  • Mr. Paul Brennan, CEO, MD & Director
  • Mr. Jan-Marcel Gielen C.A., CFO & Company Sec.
  • Mr. Gordon Fleming, Director of Operations
  • Ms. Katherine Napier, Marketing & Distributor Mang.
  • Ms. Monica Benyk, HR Mang.
  • Dr. Tim Moore, Principal Scientist
  • Mr. Edward Graubart, Sr. VP of North America

What is PolyNovo Limited (PNV.AX)'s stock symbol?

PolyNovo Limited (PNV.AX) trades on the ASX under the ticker symbol "PNV."

How big of a company is PolyNovo Limited (PNV.AX)?

PolyNovo Limited (PNV.AX) has a market capitalization of $0.00 and generates $22.19 million in revenue each year. PolyNovo Limited (PNV.AX) employs 78 workers across the globe.

What is PolyNovo Limited (PNV.AX)'s official website?

The official website for PolyNovo Limited (PNV.AX) is www.polynovo.com.au.

How can I contact PolyNovo Limited (PNV.AX)?

The company can be reached via phone at 61 3 8681 4050.

This page was last updated on 12/4/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.